These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 35976645)

  • 21. Reduction in Chest CT Severity and Improved Hospital Outcomes in SARS-CoV-2 Omicron Compared with Delta Variant Infection.
    Tsakok MT; Watson RA; Saujani SJ; Kong M; Xie C; Peschl H; Wing L; MacLeod FK; Shine B; Talbot NP; Benamore RE; Eyre DW; Gleeson F
    Radiology; 2023 Jan; 306(1):261-269. PubMed ID: 35727150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics of 310 SARS-CoV-2 Omicron variant patients and comparison with Delta and Beta variant patients in China.
    Yang W; Yang S; Wang L; Zhou Y; Xin Y; Li H; Mu W; Wu Q; Xu L; Zhao M; Wang C; Yu K
    Virol Sin; 2022 Oct; 37(5):704-715. PubMed ID: 35948265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study.
    Bouzid D; Visseaux B; Kassasseya C; Daoud A; Fémy F; Hermand C; Truchot J; Beaune S; Javaud N; Peyrony O; Chauvin A; Vaittinada Ayar P; Bourg A; Riou B; Marot S; Bloom B; Cachanado M; Simon T; Freund Y;
    Ann Intern Med; 2022 Jun; 175(6):831-837. PubMed ID: 35286147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
    Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H
    JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance.
    Filippatos F; Tatsi EB; Dellis C; Koukou DM; Papagiannopoulos C; Margeli A; Siahanidou T; Kanaka-Gantenbein C; Syriopoulou V; Michos A
    Epidemiol Infect; 2022 Oct; 150():e177. PubMed ID: 36345855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do quantitative levels of antispike-IgG antibodies aid in predicting protection from SARS-CoV-2 infection? Results from a longitudinal study in a police cohort.
    Sendi P; Widmer N; Branca M; Thierstein M; Büchi AE; Güntensperger D; Blum MR; Baldan R; Tinguely C; Heg D; Theel ES; Berbari E; Tande AJ; Endimiani A; Gowland P; Niederhauser C;
    J Med Virol; 2023 Jul; 95(7):e28904. PubMed ID: 37386901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population.
    Thi Khanh HN; Cornelissen L; Castanares-Zapatero D; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Devleesschauwer B; De Ridder K; Charafeddine R; Smith P
    BMC Infect Dis; 2023 Nov; 23(1):774. PubMed ID: 37940843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.
    Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC
    Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study.
    Cloete J; Kruger A; Masha M; du Plessis NM; Mawela D; Tshukudu M; Manyane T; Komane L; Venter M; Jassat W; Goga A; Feucht U
    Lancet Child Adolesc Health; 2022 May; 6(5):294-302. PubMed ID: 35189083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
    Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
    JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in Risk Factors and Symptoms Associated With SARS-CoV-2 and Rhinovirus Test Positivity in King County, Washington, June 2020 to July 2022.
    Hansen C; Perofsky AC; Burstein R; Famulare M; Boyle S; Prentice R; Marshall C; McCormick BJJ; Reinhart D; Capodanno B; Truong M; Schwabe-Fry K; Kuchta K; Pfau B; Acker Z; Lee J; Sibley TR; McDermot E; Rodriguez-Salas L; Stone J; Gamboa L; Han PD; Duchin JS; Waghmare A; Englund JA; Shendure J; Bedford T; Chu HY; Starita LM; Viboud C
    JAMA Netw Open; 2022 Dec; 5(12):e2245861. PubMed ID: 36484987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deaths Due to COVID-19 in Patients With Cancer During Different Waves of the Pandemic in the US.
    Potter AL; Vaddaraju V; Venkateswaran S; Mansur A; Bajaj SS; Kiang MV; Jena AB; Yang CJ
    JAMA Oncol; 2023 Oct; 9(10):1417-1422. PubMed ID: 37651113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19-Related Symptoms during the SARS-CoV-2 Omicron (B.1.1.529) Variant Surge in Japan.
    Akaishi T; Kushimoto S; Katori Y; Sugawara N; Egusa H; Igarashi K; Fujita M; Kure S; Takayama S; Abe M; Kikuchi A; Ohsawa M; Ishizawa K; Abe Y; Imai H; Inaba Y; Iwamatsu-Kobayashi Y; Nishioka T; Onodera K; Ishii T
    Tohoku J Exp Med; 2022 Sep; 258(2):103-110. PubMed ID: 36002251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nosocomial SARS-CoV-2 transmission in multi-bedded hospital cubicles over successive pandemic waves: Lower mortality but wider spread with Omicron despite enhanced infection-prevention measures.
    Wee LE; Conceicao EP; Aung MK; Aung MO; Yang Y; Arora S; Ko KK; Venkatachalam I
    Infect Dis Health; 2023 May; 28(2):81-87. PubMed ID: 37032572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critically ill children with SARS-COV-2 Omicron infection at a national children medical center, Guangdong, China.
    Lin F; Jiang DJ; Zhang S; Yang Z; Zeng HS; Liu ZP; Yang LY
    BMC Pediatr; 2024 Apr; 24(1):254. PubMed ID: 38622552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term neuropsychiatric sequelae of Delta versus Omicron SARS-CoV-2 infection.
    Wee LE; Lim JT; Tay AT; Pang D; Dickens B; Chiew CJ; Ong B; Lye DCB; Tan KB
    Clin Microbiol Infect; 2024 Apr; 30(4):531-539. PubMed ID: 38141822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
    JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study.
    Ward IL; Bermingham C; Ayoubkhani D; Gethings OJ; Pouwels KB; Yates T; Khunti K; Hippisley-Cox J; Banerjee A; Walker AS; Nafilyan V
    BMJ; 2022 Aug; 378():e070695. PubMed ID: 35918098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
    Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP;
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 IgG seropositivity after the severe Omicron wave of COVID-19 in Hong Kong.
    Poon RW; Chan BP; Chan WM; Fong CH; Zhang X; Lu L; Chen LL; Lam JY; Cheng VC; Wong SSY; Kok KH; Yuen KY; To KK
    Emerg Microbes Infect; 2022 Dec; 11(1):2116-2119. PubMed ID: 35880656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.